acebutolol has been researched along with Angor Pectoris in 36 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol, a beta-1 selective beta blocker with intrinsic sympathomimetic activity has been shown to be an effective agent in chronic angina pectoris therapy, with twice or three times daily dosing." | 9.06 | Low-dose acebutolol given once daily in the treatment of chronic angina pectoris. ( Piña, IL; Smith, EV; Weidler, DJ, 1988) |
| "The relevance of the ancillary pharmacological properties of intrinsic sympathomimetic activity (ISA) and cardioselectivity to the haemodynamic profile following intravenous beta-blockade was examined in a randomised study of propranolol (16 mg), acebutolol (160 mg) or penbutolol (4 mg) in 30 patients with stable angina pectoris." | 9.05 | Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "The clinical effects of a new cardioselective beta-adrenergic blocking drug, acebutolol hydrochloride (SECTRAL), were studied in 18 patients with angina pectoris, using graded treadmill testing according to a modified Bruce protocol." | 9.04 | Acebutolol in angina pectoris: objective assessment using graded treadmill testing. ( Gotsman, MS; Kimchi, A; Lewis, BS, 1978) |
| "The effects of the beta-adernergic blocking drug acebutolol were studied in 23 patients with angina pectoris and angiographically documented coronary artery disease." | 7.66 | Evaluation of the beta-blocking drug acebutolol in angina pectoris. ( Admon, D; Gotsman, MS; Kimchi, A; Lewis, BS; Rod, JL, 1979) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 6.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "Acebutolol, a beta-1 selective beta blocker with intrinsic sympathomimetic activity has been shown to be an effective agent in chronic angina pectoris therapy, with twice or three times daily dosing." | 5.06 | Low-dose acebutolol given once daily in the treatment of chronic angina pectoris. ( Piña, IL; Smith, EV; Weidler, DJ, 1988) |
| "The effect of chronic oral therapy with acebutolol, a cardioselective beta adrenergic blocking agent, was evaluated on resting pulmonary functions in a group of patients who were free of overt obstructive airways disease and who had chronic stable angina pectoris." | 5.05 | Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent. ( Costello, RB; DiBianco, R; Dickie, KJ; Fletcher, RD; Gottdiene, JS; Katz, RJ; Laddu, AR; Singh, S, 1982) |
| "The relevance of the ancillary pharmacological properties of intrinsic sympathomimetic activity (ISA) and cardioselectivity to the haemodynamic profile following intravenous beta-blockade was examined in a randomised study of propranolol (16 mg), acebutolol (160 mg) or penbutolol (4 mg) in 30 patients with stable angina pectoris." | 5.05 | Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris. ( Ahuja, RC; Hussain, M; Nelson, GI; Okoli, RC; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "We assessed the effects of acebutolol, a cardioselective beta blocker, on global and regional left ventricular function in 26 patients with chronic angina pectoris." | 5.05 | Acebutolol and left ventricular function: assessment by radionuclide angiography. ( Bates, HR; Bortz, R; DiBianco, R; Fletcher, RD; Katz, RJ; Laddu, AR; Sauerbrunn, B; Singh, S, 1981) |
| "The clinical effect of the beta-adrenergic blocking drug acebutolol hydrochloride (SECTRAL) was studied in 18 patients with angina pectoris." | 5.04 | Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring. ( Admon, D; Gotsman, MS; Kamchi, A; Lewis, BS, 1979) |
| "The clinical effects of a new cardioselective beta-adrenergic blocking drug, acebutolol hydrochloride (SECTRAL), were studied in 18 patients with angina pectoris, using graded treadmill testing according to a modified Bruce protocol." | 5.04 | Acebutolol in angina pectoris: objective assessment using graded treadmill testing. ( Gotsman, MS; Kimchi, A; Lewis, BS, 1978) |
| "The effects of the beta-adernergic blocking drug acebutolol were studied in 23 patients with angina pectoris and angiographically documented coronary artery disease." | 3.66 | Evaluation of the beta-blocking drug acebutolol in angina pectoris. ( Admon, D; Gotsman, MS; Kimchi, A; Lewis, BS; Rod, JL, 1979) |
| "Acebutolol treatment decreased the frequency of angina (diary cards) (placebo, 9." | 2.65 | Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease. ( Gold, F; Steele, P, 1982) |
| "Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity." | 2.37 | Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. ( Singh, BN; Thoden, WR; Ward, A, 1985) |
| "The treatment with acebutolol was effective inducing an improvement of subjective symptoms (reduction of stenocardiac crises, intensity and duration of angor, trinitrin pearls consumption) and an increase of effort tolerance." | 1.26 | [Effects of the administration of acebutolol in patients with chronic angina of effort]. ( Baroni, F; Donegani, E; Forni, B; Uslenghi, E; Zardini, P, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (97.22) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiBianco, R | 5 |
| Dickie, KJ | 1 |
| Singh, S | 3 |
| Katz, RJ | 3 |
| Costello, RB | 3 |
| Gottdiene, JS | 1 |
| Laddu, AR | 4 |
| Fletcher, RD | 5 |
| Bory, M | 1 |
| Bénichou, M | 1 |
| Witchitz, S | 1 |
| Kolsky, H | 1 |
| Moisson, P | 1 |
| Philippe, B | 1 |
| Birnbaum, J | 1 |
| Becker, KL | 1 |
| Muesing, R | 1 |
| Singh, SN | 2 |
| Gottdiener, JS | 3 |
| Silke, B | 1 |
| Nelson, GI | 1 |
| Verma, SP | 1 |
| Ahuja, RC | 1 |
| Okoli, RC | 1 |
| Hussain, M | 1 |
| Taylor, SH | 1 |
| Giannini, SD | 1 |
| Forti, N | 1 |
| Campanari, JC | 1 |
| Di Rienzo, F | 1 |
| Adler, R | 1 |
| Ziliotto, EE | 1 |
| Kern, P | 1 |
| De Biase, AM | 2 |
| Pirelli, S | 2 |
| Cataldo, G | 2 |
| Salvadè, P | 2 |
| Carù, B | 2 |
| De Ponti, C | 2 |
| Singh, JB | 1 |
| Bortz, R | 2 |
| Spodick, DH | 1 |
| Strasser, R | 1 |
| Klepzig, H | 1 |
| Shah, PM | 1 |
| Newton, GC | 1 |
| Miller, RR | 1 |
| Nahormek, P | 1 |
| Scrutinio, D | 1 |
| De Toma, L | 1 |
| Mangini, S | 1 |
| Boscia, F | 1 |
| Quagliara, D | 1 |
| De Nicolò, M | 1 |
| Rizzon, P | 1 |
| Lanocita, M | 1 |
| Steele, P | 1 |
| Gold, F | 1 |
| Beugin, JP | 1 |
| Caux, G | 1 |
| Gamblin, J | 1 |
| Bisch, JF | 1 |
| Cornaert, P | 1 |
| Dutoit, A | 1 |
| Croccel, L | 1 |
| Uslenghi, E | 1 |
| Donegani, E | 1 |
| Forni, B | 1 |
| Baroni, F | 1 |
| Zardini, P | 1 |
| Shapiro, A | 1 |
| Kimchi, A | 3 |
| Rod, JL | 2 |
| Gotsman, MS | 4 |
| Lewis, BS | 4 |
| Bates, HR | 1 |
| Sauerbrunn, B | 1 |
| Murakami, H | 1 |
| Nishimura, M | 1 |
| Urabe, K | 1 |
| Biron, P | 4 |
| Tremblay, G | 4 |
| Frick, MH | 1 |
| Valle, M | 1 |
| Korhola, O | 1 |
| Hekali, P | 1 |
| Riihimäki, E | 1 |
| Proulx, A | 2 |
| Admon, D | 2 |
| Kamchi, A | 1 |
| Fiserová, J | 1 |
| Hlavácek, K | 1 |
| Vávra, M | 1 |
| Holík, F | 1 |
| Münz, J | 1 |
| Rey, G | 1 |
| Wazana, M | 1 |
| Sacrez, A | 1 |
| Halawa, B | 1 |
| Romeo, F | 1 |
| Gaspardone, A | 1 |
| Ciavolella, M | 1 |
| Gioffrè, P | 1 |
| Reale, A | 1 |
| Miller, NE | 1 |
| Nanjee, MN | 1 |
| Rajput-Williams, J | 1 |
| Coltart, DJ | 1 |
| Piña, IL | 1 |
| Smith, EV | 1 |
| Weidler, DJ | 1 |
| Tirlapur, VG | 1 |
| Evans, PJ | 1 |
| Jones, MK | 1 |
| de Roquefeuil, F | 1 |
| Goupil, C | 1 |
| Singh, BN | 1 |
| Thoden, WR | 1 |
| Ward, A | 1 |
| Pandhi, P | 1 |
| Sethi, V | 1 |
| Sharma, BK | 1 |
| Wahi, PL | 1 |
| Sharma, PL | 1 |
| Nadeau, R | 1 |
1 review available for acebutolol and Angor Pectoris
| Article | Year |
|---|---|
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Topics: Acebutolol; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Vessels; B | 1985 |
20 trials available for acebutolol and Angor Pectoris
| Article | Year |
|---|---|
Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Bli | 1982 |
Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blin | 1983 |
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Topics: Acebutolol; Adult; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Exer | 1984 |
[Effects of the combination nifedipine-acebutolol in patients with stable angina pectoris. Comparative double-blind study with the same drugs used separately].
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therap | 1983 |
[Effects of nifedipine and acebutolol alone and combined on work capacity in patients with exertional angina].
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Nifedipine | 1981 |
Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study.
Topics: Acebutolol; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Drug Evalua | 1980 |
Comparison of the antianginal efficacy of acebutolol and propranolol. A multicenter, randomized, double-blind placebo-controlled study.
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Hemodynamic | 1982 |
[Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Exercise Test; Heart; Hemodynamics; Humans; M | 1981 |
Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinatio | 1981 |
Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Humans; M | 1982 |
Ocular effects of acebutolol and propranolol.
Topics: Acebutolol; Angina Pectoris; Humans; Intraocular Pressure; Lacrimal Apparatus; Propranolol | 1980 |
Acebutolol and left ventricular function: assessment by radionuclide angiography.
Topics: Acebutolol; Angina Pectoris; Blood Pressure; Coronary Disease; Coronary Vessels; Exercise Test; Hear | 1981 |
Acebultolol: basis for the prediction of effect on exercise tolerance.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Coronary Disease; E | 1976 |
Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Clinical Tria | 1979 |
Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
Topics: Acebutolol; Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Exercise Test; Female; | 1978 |
Differential antianginal responsiveness to acebutolol.
Topics: Acebutolol; Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Dose | 1975 |
Verapamil versus acebutolol for syndrome X.
Topics: Acebutolol; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mi | 1988 |
Double-blind trial of the long-term effects of acebutolol and propranolol on serum lipoproteins in patients with stable angina pectoris.
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Hum | 1987 |
Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
Topics: Acebutolol; Adult; Aged; Aged, 80 and over; Angina Pectoris; Electrocardiography; Female; Humans; Hy | 1988 |
Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Hum | 1985 |
15 other studies available for acebutolol and Angor Pectoris
| Article | Year |
|---|---|
[Comparison of the action of beta-blockers and calcium inhibitors in the treatment of primary angina pectoris].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Coronary | 1983 |
[Beta-blockers in effort angina].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Ex | 1983 |
[Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Dru | 1981 |
[Study of acebutolol in angina pectoris with ergometric evaluation].
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Blood Pressure; Female; Heart Function Tests; Heart Rate; | 1982 |
[Effects of the administration of acebutolol in patients with chronic angina of effort].
Topics: Acebutolol; Adult; Angina Pectoris; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Age | 1981 |
Relation between dynamic midventricular obstruction and unexplained chest pain in patients with normal echocardiograms at rest.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angina P | 1996 |
Response of left ventricular myocardial perfusion and cavity size to beta-blockade by acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Circulation; Heart Ventric | 1978 |
Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Exercise Test; Female; Humans | 1978 |
Acebutol (Sectral) in angina pectoris treatment.
Topics: Acebutolol; Angina Pectoris; Female; Humans; Male; Middle Aged | 1979 |
Evaluation of the beta-blocking drug acebutolol in angina pectoris.
Topics: Acebutolol; Adult; Aged; Angina Pectoris; Drug Evaluation; Electrocardiography; Exercise Test; Femal | 1979 |
[Use of acebutolol in angina pectoris].
Topics: Acebutolol; Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Electrocardiography; Humans; Mid | 1978 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; | 1987 |
Shock syndrome after acebutolol.
Topics: Acebutolol; Angina Pectoris; Humans; Male; Middle Aged; Shock | 1986 |
[Sectral].
Topics: Acebutolol; Angina Pectoris; Arrhythmias, Cardiac; Humans; Hypertension | 1985 |
[Anti-arrhythmic and anti-anginal properties of acebutolol].
Topics: Acebutolol; Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardi | 1974 |